Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|January 1, 1993
Semi-automated cervical smear pre-screening systems: an evaluation of the Cytoscan-110O A Husain, K C Watts, F Lorriman, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2010
Interferon-inducible factor 16 is a novel modulator of glucocorticoid actionA Berry, L Matthews, M Jangani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 8, 2016
Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review dataP MacPherson, S B Squire, P Cleary, et al.
Nature|October 12, 1989
Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursorW E Van Nostrand, S L Wagner, M Suzuki, et al.
Annals of Neurology|August 1, 1994
Decreased levels of soluble amyloid beta-protein precursor are associated with Alzheimer's disease in concordant and discordant monozygous twin pairsS L Wagner, E R Peskind, D Nochlin, et al.
Brain Research|October 29, 1993
Co-distribution of protease nexin-1 and protease nexin-2 in brains of non-human primatesS L Wagner, W E Van Nostrand, A L Lau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patientsW E Van Nostrand, S L Wagner, W R Shankle, et al.
The Journal of Hospital Infection|December 28, 2024
Development and evaluation of a high-fidelity, multi-disciplinary simulation training course for high-consequence infectious diseases using fluorescence visualizationL Hunt, J Cole, C Evans, et al.
Arthritis and Rheumatism|December 17, 2002
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trialE H S Choy, D A Isenberg, T Garrood, et al.
American Journal of Human Biology : the Official Journal of the Human Biology Council|September 5, 2001
Role of genetic and environmental factors in the increased blood pressures of Bolivian blacksA. Roberto Frisancho, S. Farrow, Isabel Friedenzohn, et al.
Pageof 10